Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
Also known as: Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) / Refractory or Relapsed B-cell Non-Hodgkin Lymphoma / Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma / Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma / Relapsed or Refractory B Cell Non-Hodgkin Lymphoma / Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17362 | Obecabtagene autoleucel | 1 | Recruiting | 1 |
DB12887 | Tazemetostat | 1 | Completed | 1 |
DB06769 | Bendamustine | 1 / 2 | Unknown Status | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Unknown Status | 1 |
DB12218 | Capivasertib | 2 | Active Not Recruiting | 1 |
DB12887 | Tazemetostat | 2 | Completed | 1 |
DB06334 | Tucidinostat | 2 | Recruiting | 1 |
DB00928 | Azacitidine | Not Available | Enrolling by Invitation | 1 |
DB00531 | Cyclophosphamide | Not Available | Enrolling by Invitation | 1 |
DB01073 | Fludarabine | Not Available | Enrolling by Invitation | 1 |
DB00480 | Lenalidomide | Not Available | Enrolling by Invitation | 1 |
DB08935 | Obinutuzumab | Not Available | Enrolling by Invitation | 1 |
DB15035 | Zanubrutinib | Not Available | Enrolling by Invitation | 1 |